Washington Research Foundation
Facts
- HQ
- Washington State
- Sectors
- Non-profit Organizations
- Founded
- 1981
- Employees
- 22
- Founders
- Tom Cable, Bill Gates, Sr., Hunter Simpson
BrainChild Bio raises $116M Series A to launch pivotal registrational trial of BCB-276 CAR T therapy for pediatric DIPG
BrainChild Bio, a Seattle Children’s spinout, raised $116 million in Series A funding to support a pivotal registrational trial of BCB-276, an autologous CAR T-cell therapy targeting DIPG in children, with plans to expand into adult CNS tumors including glioblastoma.
BrainChild Bio raises $116M Series A from Seattle Children’s and WRF to fund pivotal CAR-T trial for DIPG
BrainChild Bio, spun out of Seattle Children’s Hospital, raised $116 million in a Series A led by Seattle Children’s and WRF Capital to fund a pivotal phase 2 trial of CAR-T candidate BCB-276 for diffuse intrinsic pontine glioma (DIPG) and advance a planned phase 1 glioblastoma program.
Washington Research Foundation names Ankit K. Azad to ninth Venture Analyst cohort to evaluate health-tech grants and startups
The Washington Research Foundation named Kolkata-born consultant Ankit K. Azad to its ninth cohort of Venture Analysts, bringing his life sciences and healthcare commercial strategy experience to evaluate grant applications and early-stage startups. Azad, a former ZS Associates consultant and current MBA candidate at the University of Washington Foster School of Business, will work part-time with the Seattle-based foundation to assess the commercial viability of scientific discoveries from Washington research institutions.
People
-
William Canestaro Managing Director
